Respiratory Cilia

1. Location

  • Found lining the conducting airways from the nasal cavity down to the terminal bronchioles.
  • The epithelium is pseudostratified ciliated columnar epithelium.
  • Note: Cilia are absent in the alveoli and respiratory bronchioles (gas exchange zones).

2. Structure (The Axoneme)

  • Arrangement: Characterized by the classic “9 + 2” microtubular arrangement.
    • 9 peripheral microtubule doublets.
    • 2 central single microtubules.
  • Key Components:
    • Dynein Arms (Inner & Outer): ATPase motor proteins attached to microtubules that generate force for movement. Defects here cause PCD.
    • Radial Spokes: Connect peripheral doublets to the central sheath.
    • Nexin Links: Elastic proteins connecting adjacent doublets.

3. Function

  • Mucociliary Clearance (The “Escalator”): Cilia beat in a coordinated, rhythmic wave (Metachronal rhythm) at 10–15 Hz.
  • Mechanism: They propel the overlying mucus layer (trapping dust, bacteria, and debris) cephalad (towards the pharynx) to be swallowed or expectorated.
  • Host Defense: Primary innate defense mechanism preventing lower respiratory tract infections.

Primary Ciliary Dyskinesia (PCD)

1. Introduction

  • Definition: A genetically heterogeneous, autosomal recessive disorder characterized by abnormal ciliary structure or function, leading to impaired mucociliary clearance.
  • Incidence: 1 in 15,000 – 30,000.
  • Kartagener Syndrome: A subgroup of PCD (~50%) characterized by the triad:
    1. Situs Inversus.
    2. Chronic Sinusitis.
    3. Bronchiectasis.

2. Clinical Presentation

Symptoms often begin in the neonatal period and persist.

  • Neonatal Period (High Index of Suspicion):

    • Unexplained Respiratory Distress: Term infant requiring without risk factors (e.g., Meconium, sepsis).
    • Neonatal Rhinitis: Continuous nasal discharge from birth.
  • Childhood & Adolescence:

    • Respiratory:
      • Chronic Wet Cough: Daily, year-round, starting in infancy.
      • Recurrent Pneumonia: Leading to early Bronchiectasis (lower lobes).
      • Intractable Asthma: “Difficult asthma” unresponsive to treatment.
    • ENT:
      • Chronic Rhinosinusitis: Nasal polyps are rare (unlike CF) but congestion is constant.
      • Chronic Otitis Media with Effusion (OME): Conductive hearing loss is almost universal.
    • Situs Abnormalities: Situs inversus totalis or situs ambiguus (heterotaxy).
  • Adulthood:

    • Infertility:
      • Males: Immotile sperm (sperm flagella have same 9+2 structure).
      • Females: Risk of ectopic pregnancy (tubal cilia dysfunction) or subfertility.

3. Diagnosis

Diagnosis is challenging and requires a tiered approach.

  • Screening Test:

    • Nasal Nitric Oxide (nNO): Levels are extremely low (<77 nL/min) in PCD (cilia regulate NO production). Gold standard screening test in children >5 years.
  • Confirmatory Tests:

    1. High-Speed Video Microscopy (HSVM): Analyzes ciliary beat frequency and pattern from nasal brush biopsy.
    2. Transmission Electron Microscopy (TEM): Visualizes structural defects (e.g., absent dynein arms).
    3. Genetic Testing: Panels testing for DNAH5, DNAI1 (common mutations).

4. Management

There is no curative therapy. Management is supportive, largely adapted from Cystic Fibrosis protocols.

A. Airway Clearance (The Cornerstone)

  • Chest Physiotherapy: Twice daily percussion/vibration or oscillatory PEP devices (Flutter/Acapella).
  • Exercise: Encouraged to promote deep breathing and cough.

B. Infection Control

  • Surveillance: Routine sputum cultures (every 3 months).
  • Antibiotics:
    • Acute Exacerbations: Aggressive treatment (Oral/IV) for 14–21 days.
    • Prophylaxis: Long-term Azithromycin (anti-inflammatory + antibacterial) is often used.
    • Nebulized Antibiotics: For chronic Pseudomonas colonization.

C. ENT Management

  • Hearing: Hearing aids are often preferred over grommets (ventilation tubes) because grommets often have persistent purulent discharge in PCD.
  • Sinusitis: Saline nasal douches and nasal steroids.

D. Monitoring

  • Spirometry: Monitor FEV1 for decline.
  • Vaccination: Influenza and Pneumococcal vaccines are mandatory.

5. Prognosis

  • Generally better than Cystic Fibrosis.
  • Slow decline in lung function; end-stage lung disease may require transplantation in adulthood.